Spain, March 20 -- Spain based ROCHE FARMA, S.A.U. has secured contract from SERVICIO RIOJANO DE SALUD for Pharmaceutical Products - Supply of exclusive drugs Tecentriq (Pa atezolizumab), Alecense (Pa Alecitinib), Gazyvaro (PA Obinutuzumab) and Perjeta (PA Pertuzumab) destined for the pharmacy services of the Rioja de Salud service. The value of the contract is worth 80875350 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....